Royal Bank of Canada
DAWN

Royal Bank of Canada’s Day One Biopharmaceuticals DAWN Stock Holding History

Royal Bank of Canada’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41K Sell
1,911
-2,197
-53% -$31K ﹤0.01% 5583
2025
Q4 		$38K Sell
4,108
-39,891
-91% -$333K ﹤0.01% 5688
2025
Q3 		$310K Sell
43,999
-130,975
-75% -$901K ﹤0.01% 4810
2025
Q2 		$1.14M Sell
174,974
-10,759
-6% -$74K ﹤0.01% 3788
2025
Q1 		$1.47M Buy
185,733
+53,459
+40% +$576K ﹤0.01% 3178
2024
Q4 		$1.68M Buy
132,274
+95,625
+261% +$1.33M ﹤0.01% 3135
2024
Q3 		$511K Buy
36,649
+29,534
+415% +$421K ﹤0.01% 4083
2024
Q2 		$98K Buy
7,115
+3,409
+92% +$49.9K ﹤0.01% 5275
2024
Q1 		$61K Sell
3,706
-17,514
-83% -$262K ﹤0.01% 5449
2023
Q4 		$310K Buy
21,220
+11,499
+118% +$139K ﹤0.01% 4700
2023
Q3 		$119K Buy
9,721
+4,840
+99% +$63.1K ﹤0.01% 5265
2023
Q2 		$59K Buy
4,881
+2,077
+74% +$27.1K ﹤0.01% 5691
2023
Q1 		$37K Sell
2,804
-1,535
-35% -$30K ﹤0.01% 5775
2022
Q4 		$93K Buy
4,339
+2,832
+188% +$58.1K ﹤0.01% 5504
2022
Q3 		$30K Buy
1,507
+231
+18% +$4.91K ﹤0.01% 5976
2022
Q2 		$22K Sell
1,276
-1,266
-50% -$13.1K ﹤0.01% 6064
2022
Q1 		$25K Sell
2,542
-763
-23% -$10.1K ﹤0.01% 6482
2021
Q4 		$55K Buy
3,305
+1,929
+140% +$39.6K ﹤0.01% 6316
2021
Q3 		$33K Buy
+1,376
New +$33K ﹤0.01% 6400

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Royal Bank of Canada's DAWN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Day One Biopharmaceuticals (DAWN) stake by 53% in Q1 2026, selling an estimated $31K and leaving 1,911 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #5583.

Royal Bank of Canada first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.68M in Q4 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Royal Bank of Canada held 1,911 shares of Day One Biopharmaceuticals worth $41K as of Q1 2026.
  • Royal Bank of Canada sold 2,197 Day One Biopharmaceuticals shares in Q1 2026, an estimated $31K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5583 holding.
  • Royal Bank of Canada first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Day One Biopharmaceuticals position peaked at $1.68M in Q4 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.